4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001104659-17-022530
Options or other derivatives
- CEO acquired 130,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
WELCH WILLIAM J · CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-04-07 | Grant or award : show line 1 in the form Restricted Stock Units | +130,000 | 330,000 | D |
Loading xslF345X03/a4.xml…